science, drawing and technology to advance dementia research
A collaborative research project between:
New Zealand’s Massey University and
France’s Institut Claude Pompidou and
Institut de Chimie de Nice, Université Côte d’Azur
Dementia is an umbrella term used to describe a group of symptoms that change and damage the brain.
Alzheimer's Disease (AD) is the most common cause of dementia.
The most common symptoms include changes in memory, thinking, behaviour, personality and emotion. Dementia is progressive and cannot be prevented or cured. Because its frequency increases with age, the number of people it strikes grows as the population ages.
According to the World Alzheimer’s Report 2015 the number of people with dementia worldwide will nearly double every 20 years. Therefore, it is even more relevant than ever before to bring together research expertise from France and New Zealand to develop methodologies that engage the human senses for early diagnosis, recall, stimulation, autonomy and art therapy for people with dementia.
Drawing to help maintain fine motor skills and to improve communication, wellbeing and self-esteem in people with dementia and their supporters.
Evaluating the potential influence of odour to artistic production and how these findings can then be potentially applied to enhance cognitive performance.
Studying writing/drawing to help early diagnosis of Alzheimer’s Disease (AD) and Frontotemporal Lobar Degeneration (FTLD).
Supported by
MeDArt's three projects has been reviewed and endorsed by Alzheimers New Zealand and by Dementia Wellington.
Fundraising for MeDArT is being done through Massey University's charitable arm; the Massey University Foundation.